- Home
- SBRA vs ICUI Comparison
SBRA vs ICUI Comparison
Compare SBRA & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBRA
- ICUI
- Stock Information
- Founded
- SBRA 2010
- ICUI 1984
- Country
- SBRA United States
- ICUI United States
- Employees
- SBRA N/A
- ICUI N/A
- Industry
- SBRA Real Estate Investment Trusts
- ICUI Medical/Dental Instruments
- Sector
- SBRA Real Estate
- ICUI Health Care
- Exchange
- SBRA Nasdaq
- ICUI Nasdaq
- Market Cap
- SBRA 4.3B
- ICUI 3.8B
- IPO Year
- SBRA N/A
- ICUI 1992
- Fundamental
- Price
- SBRA $16.80
- ICUI $161.08
- Analyst Decision
- SBRA Buy
- ICUI Buy
- Analyst Count
- SBRA 7
- ICUI 4
- Target Price
- SBRA $19.57
- ICUI $199.67
- AVG Volume (30 Days)
- SBRA 2.0M
- ICUI 200.3K
- Earning Date
- SBRA 02-25-2025
- ICUI 02-25-2025
- Dividend Yield
- SBRA 7.14%
- ICUI N/A
- EPS Growth
- SBRA N/A
- ICUI N/A
- EPS
- SBRA 0.41
- ICUI N/A
- Revenue
- SBRA $682,324,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- SBRA N/A
- ICUI $4.38
- Revenue Next Year
- SBRA $7.23
- ICUI $0.34
- P/E Ratio
- SBRA $41.18
- ICUI N/A
- Revenue Growth
- SBRA 20.53
- ICUI 4.04
- 52 Week Low
- SBRA $12.83
- ICUI $86.80
- 52 Week High
- SBRA $20.03
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- SBRA 42.54
- ICUI 51.79
- Support Level
- SBRA $16.35
- ICUI $151.92
- Resistance Level
- SBRA $17.27
- ICUI $167.49
- Average True Range (ATR)
- SBRA 0.37
- ICUI 4.52
- MACD
- SBRA 0.01
- ICUI 0.73
- Stochastic Oscillator
- SBRA 44.55
- ICUI 61.01
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.